We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 5,565 results

  1. Isolation and Purification of Mycobacterial Extracellular Vesicles (EVs)

    Bacterial extracellular vesicles (EVs) contain numerous active substances that mediate bacterial interactions with their host and with other...
    Komal Umashankar Rao, Gabriela Godaly in Bacterial Pathogenesis
    Protocol 2023

  3. Geriatric nutritional risk index as a prognostic factor in elderly patients with non-muscle-invasive bladder cancer: a propensity score-matched study

    Purpose

    The Geriatric Nutrition Risk Index (GNRI) is a simple and validated tool used to assess the nutritional status of elderly patients and predict...

    **gxin Wu, **aofeng Cheng, ... Gongxian Wang in International Urology and Nephrology
    Article 04 January 2024

  4. BCG

    in Reactions Weekly
    Article 26 August 2023

  5. BCG

    in Reactions Weekly
    Article 25 May 2024

  6. NMIBC—BCG Refractory Disease and Use of Interferon

    Thirty to forty percent of patients with high grade nonmuscle invasive bladder cancer (NMIBC) fail to respond to intravesical therapy with bacillus...
    Sanchia S. Goonewardene, Raj Persad, ... David Albala in Management of Non-Muscle Invasive Bladder Cancer
    Chapter 2020

  7. The Clinical Reality of Granulomatous Prostatitis

    Purpose of Review

    Granulomatous prostatitis is a rare inflammatory disease of the prostate. It is challenging for the clinician because it mimics...

    A. Hanssen, C. Vrij, J. Heesakkers in Current Bladder Dysfunction Reports
    Article Open access 28 February 2024

  9. Multiple drugs

    in Reactions Weekly
    Article 13 July 2024

  11. BCG-vaccine

    in Reactions Weekly
    Article 30 March 2024

  12. BCG

    in Reactions Weekly
    Article 23 March 2024

  13. Can random bladder biopsies be eliminated after bacillus Calmette–Guérin therapy against carcinoma in situ?

    Purpose

    Intravesical bacillus Calmette–Guérin (BCG) is the standard of care for bladder carcinoma in situ (CIS). The response to BCG therapy against...

    Kimiharu Takamatsu, Kazuhiro Matsumoto, ... Mototsugu Oya in International Urology and Nephrology
    Article 06 October 2020

  14. Impact of sex on response to BCG in non-muscle invasive bladder cancer patients: a contemporary review from a tertiary care center

    Purpose

    Female sex has been implicated with higher stage at diagnosis and as a negative prognostic factor amongst patients with non-muscle invasive...

    Kelly K. Bree, Patrick J. Hensley, ... Ashish M. Kamat in World Journal of Urology
    Article 12 June 2021

  15. The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity

    The International Union of Immunological Societies (IUIS) expert committee (EC) on Inborn Errors of Immunity (IEI) reports here the 2022 updated...

    Aziz Bousfiha, Abderrahmane Moundir, ... Isabelle Meyts in Journal of Clinical Immunology
    Article 06 October 2022

  16. Intravesical Pseudomonas aeruginosa mannose-sensitive Hemagglutinin vaccine triggers a tumor-preventing immune environment in an orthotopic mouse bladder cancer model

    Bacillus Calmette-Guerin (BCG) immunotherapy can prevent recurrence and progression in selected patients with non-muscle-invasive bladder cancer...

    Bo Wang, Zhihua He, ... Jian Huang in Cancer Immunology, Immunotherapy
    Article 31 October 2021

  17. BCG

    in Reactions Weekly
    Article 04 May 2024

  18. BCG

    in Reactions Weekly
    Article 09 September 2023

  19. BCG-vaccine

    in Reactions Weekly
    Article 05 August 2023

  20. Multiple drugs

    in Reactions Weekly
    Article 16 July 2022
Did you find what you were looking for? Share feedback.